What is PFE's current stock price?

As of now, PFE is trading at $26.44, with a daily change of +1.34%.

What are the risks associated with PFE stock?

PFE has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

PFE Stock Analysis & IQ Rating | Pfizer

PFE

Pfizer

$26.44

+$0.35 | +1.34%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$27.69

MKT CAP

$150.33B

52W Low

$20.92

VOL

$45.82M

P/E Ratio

15.36

AVG VOL

$48.71M

RSI

60.17

TREND

Uptrend

PFE Stock IQ

Login to see Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

PFE Target Price

Login to display

Strengths

PFE Rewards

Earnings are forecast to grow

PFE Rewards

Trading below its fair value

PFE Rewards

Upgraded on attractively valued

PFE Rewards

Investors confidence is positive

PFE Price Performance

$25.17 (+5.05%)

$24.61 (+7.44%)

$24.71 (+7.00%)

$25.56 (+3.44%)

1year

6month

3month

1month

PFE Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

PFE Analysts Opinion

PFE Analysts opinion is positive but there was a setback from the past 3 months

PFE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

57%

67%

PFE Street Sentiment

PFE Street Sentiment is bullish and have positive views on the near-term outlook

PFE Risk Level

PFE has Low risk level

Low

LOW

HIGH

PFE Performance Sentiment

Sentiments overview associated with events and the stock performance

74%

19%

Positive

Negative

42 out of 57
events present

11 out of 57
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$25.86

Resistance
Price

$24.90

Current Price Range

$26.50

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

43%

Buy

Hold

Sell

Consensus Rating

NEUTRAL

3

4

0

Date

Action

Rating

Firm

Jan 16, 2026

Initiate

Neutral

UBS

Jan 12, 2026

Initiate

Neutral

UBS

Dec 30, 2025

Reiterate

Buy

Scotiabank

Dec 22, 2025

Downgrade

Hold

Dec 17, 2025

Reiterate

Buy

Guggenheim

Linked to PFE

Close Price

Change

NVS

Novartis AG

148.68

-0.16%

NVO

Novo Nordisk A/S

59.43

+0.17%

AZN

Astrazeneca

92.77

+0.19%

SNY

Sanofi

47.04

+1.82%

MRK

Merck Company

110.27

+1.80%

Recently Viewed

Close Price

Change

PFE

Pfizer

26.44

+1.34%

CYBR

CyberArk Software Lt

430.83

+0.39%

RBRK

Rubrik Inc.

55.95

-3.47%

VRM

Vroom

19.26

-12.45%

LFMD

LifeMD

3.24

-3.86%

PFE Latest Analysis +

Should You Buy Sell or Hold Pfizer Stock Ahead of Q4 Earnings?. PFE heads into Q4 earnings with strong oncology and Vyndaqel demand but IRA headwinds COVID declines and falling estimates weigh on the outlook

Fri Jan 30, 2026

$26.44 | +1.34%

Earnings

Potential

Pfizer: Buyer Beware The Risk Outweighs The Reward.

Fri Jan 30, 2026

$26.44 | +1.34%

Activity

Potential

Ahead of Pfizer (PFE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics. Get a deeper insight into the potential performance of Pfizer (PFE) for the quarter ended December 2025 by going beyond Wall Streets top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Thu Jan 29, 2026

$26.10 | +0.93%

Earnings

Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline. Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now. On January 20 Novavax announced a non-exclusive licensing agreement with Pfizer granting the pharmaceutical giant access to its Matrix-M adjuvant tech. This technology is designed to boost immune responses to vaccines and will be utilized by Pfizer for up to two infectious [….]

Thu Jan 29, 2026

$26.10 | +0.93%

Activity

Potential

Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline. Pfizer (PFE) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tue Jan 27, 2026

$26.50 | +2.40%

Earnings

Why Is Pfizer Stock Rising Tuesday?. ) shares are trading higher on Tuesday as the stock benefits from a price forecast increase at The firm raised its forecast to $27 from $24 providing a catalyst for the pharmaceutical giant even as the broader healthcare sector declined 1.6% during the session.The move stands out against mixed market performance with the S&.P 500 gaining 0.42% and the Nasdaq climbing 0.89% while the Dow Jones Industrial Average fell 1.01%.Pfizer has been active on multiple

Tue Jan 27, 2026

$26.50 | +2.40%

Momentum

Potential

Pfizer: The Great Healthcare Plan Does Not Change My ish Stance.

Tue Jan 27, 2026

$26.50 | +2.40%

Activity

Recent Report Shows That Rep. French Hill Sold Up to $365K Worth of Pfizer Stock. A January filing shows that Representative French Hill reported a sale in Pfizer (NYSE:) valued between $131004 and $365000. The transaction date is listed as December 31 2025 with the report published on January 23 2026.At present Pfizer shares are trading up 0.1% at $25.68.In the past three years French Hill made 30 stock trades totaling more than $908 thousand. The largest trades involved stocks like Philip Morr

Mon Jan 26, 2026

$25.88 | +0.90%

Activity

Momentum

Pfizer CEO Calls RFKs Vaccine Views Anti-Science Warns US Falling Behind China In Health Research. ) CEO He suggested that meaningful progress on immunization policy would require a change in leadership at the United States Department of Health and Human Services.Speaking Wednesday at a Wall Street Journal event during the World Economic Forum in Davos Switzerland Bourla said discussions with Kennedy break down when despite productive exchanges on other healthcare topics.Bourla WSJ that talks

Fri Jan 23, 2026

$25.65 | -0.04%

Momentum

The Top Stock to Buy With $30 for 2026. Key PointsPfizers financial results over the next few years likely wont be strong.

Fri Jan 23, 2026

$25.65 | -0.04%

Activity

Potential

FAQ About PFE Stock Insights

What is PFE current stock price?

What are PFE stock strengths?

What is PFE Risk Level?

What is PFE market cap and volume?

What is PFE current Stock IQ?

Should I buy PFE stock right now?

Is PFE a Strong Buy right now?

What does a 'Strong Buy' rating mean for PFE?

What does a 'Strong Sell' rating mean for PFE?

What factors influence PFE's Stock IQ?

Explore our PFE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored PFE Stock Strategies
Effective Risk Management

FIND US ON

Receive our PFE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

PFE

Pfizer

Set Alerts

Current Price

$26.44

+$0.35 | +1.34%

52W High

$27.69

MKT CAP

$150.33B

52W Low

$20.92

VOL

$45.82M

P/E Ratio

15.36

AVG VOL

$48.71M

RSI

60.17

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Linked to PFE

Symbol

Close

Change

NVS

Novartis AG

148.68

-0.16%

NVO

Novo Nordisk A/S

59.43

+0.17%

AZN

Astrazeneca

92.77

+0.19%

SNY

Sanofi

47.04

+1.82%

MRK

Merck Company

110.27

+1.80%

PFE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

57%

67%

PFE Street Sentiment

PFE Street Sentiment is bullish and have positive views on the near-term outlook

PFE Risk Level

PFE has Low risk level

Low

LOW

HIGH

PFE Performance Sentiment

Sentiments overview associated with events and the stock performance.

74%

19%

Positive

Negative

42 out of 57
events present

11 out of 57
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$25.86

Resistance
Price

$24.90

Current Price Range

$26.50

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

43%

Buy

Hold

Sell

Consensus Rating

NEUTRAL

3

4

0

Date

Action

Rating

Firm

Jan 16, 2026

Initiate

Neutral

UBS

Jan 12, 2026

Initiate

Neutral

UBS

Dec 30, 2025

Reiterate

Buy

Scotiabank

Dec 22, 2025

Downgrade

Hold

Dec 17, 2025

Reiterate

Buy

Guggenheim

PFE Stock IQ

Login to unlock Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

PFE Rewards

Earnings are forecast to grow

PFE Rewards

Trading below its fair value

PFE Rewards

Upgraded on attractively valued

PFE Rewards

Investors confidence is positive

PFE Latest Analysis

Should You Buy Sell or Hold Pfizer Stock Ahead of Q4 Earnings?. PFE heads into Q4 earnings with strong oncology and Vyndaqel demand but IRA headwinds COVID declines and falling estimates weigh on the outlook

Fri Jan 30, 2026

$26.44 | +1.34%

Earnings

Potential

Pfizer: Buyer Beware The Risk Outweighs The Reward.

Fri Jan 30, 2026

$26.44 | +1.34%

Activity

Potential

Ahead of Pfizer (PFE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics. Get a deeper insight into the potential performance of Pfizer (PFE) for the quarter ended December 2025 by going beyond Wall Streets top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Thu Jan 29, 2026

$26.10 | +0.93%

Earnings

Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline. Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now. On January 20 Novavax announced a non-exclusive licensing agreement with Pfizer granting the pharmaceutical giant access to its Matrix-M adjuvant tech. This technology is designed to boost immune responses to vaccines and will be utilized by Pfizer for up to two infectious [….]

Thu Jan 29, 2026

$26.10 | +0.93%

Activity

Potential

Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline. Pfizer (PFE) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tue Jan 27, 2026

$26.50 | +2.40%

Earnings

Why Is Pfizer Stock Rising Tuesday?. ) shares are trading higher on Tuesday as the stock benefits from a price forecast increase at The firm raised its forecast to $27 from $24 providing a catalyst for the pharmaceutical giant even as the broader healthcare sector declined 1.6% during the session.The move stands out against mixed market performance with the S&.P 500 gaining 0.42% and the Nasdaq climbing 0.89% while the Dow Jones Industrial Average fell 1.01%.Pfizer has been active on multiple

Tue Jan 27, 2026

$26.50 | +2.40%

Momentum

Potential

Pfizer: The Great Healthcare Plan Does Not Change My ish Stance.

Tue Jan 27, 2026

$26.50 | +2.40%

Activity

Recent Report Shows That Rep. French Hill Sold Up to $365K Worth of Pfizer Stock. A January filing shows that Representative French Hill reported a sale in Pfizer (NYSE:) valued between $131004 and $365000. The transaction date is listed as December 31 2025 with the report published on January 23 2026.At present Pfizer shares are trading up 0.1% at $25.68.In the past three years French Hill made 30 stock trades totaling more than $908 thousand. The largest trades involved stocks like Philip Morr

Mon Jan 26, 2026

$25.88 | +0.90%

Activity

Momentum

Pfizer CEO Calls RFKs Vaccine Views Anti-Science Warns US Falling Behind China In Health Research. ) CEO He suggested that meaningful progress on immunization policy would require a change in leadership at the United States Department of Health and Human Services.Speaking Wednesday at a Wall Street Journal event during the World Economic Forum in Davos Switzerland Bourla said discussions with Kennedy break down when despite productive exchanges on other healthcare topics.Bourla WSJ that talks

Fri Jan 23, 2026

$25.65 | -0.04%

Momentum

The Top Stock to Buy With $30 for 2026. Key PointsPfizers financial results over the next few years likely wont be strong.

Fri Jan 23, 2026

$25.65 | -0.04%

Activity

Potential

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of PFE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our PFE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

PFE Stock trends

PFE Stock performance

PFE Stock analysis

PFE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing PFE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing PFE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

PFE Stock Analysis & IQ Rating | Pfizer

PFE Stock IQ

PFE Target Price

PFE Analysts Opinion

PFE Street Sentiment

PFE Risk Level

PFE Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our PFE Stock insights

Receive our PFE Daily Alerts

PFE Street Sentiment

PFE Risk Level

Key Price Levels

Latest Analyst Actions

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of PFE. We're here to help you make informed investment decisions today.

Receive our PFE Daily Alerts

PFE Alerts